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Myo-inositol, the precursor in the biosynthesis of inositol phospholipids and inositol phosphates, is found in many tissues at concentrations 
well above its concentration in the plasma, but the highest concentrations are found in the central nervous system and the neuroretina. We 
describe an active, sodium gradient-dependent transport of myo-inositol into cultured endothelial cells derived from bovine retinal microvessels. 
Transport is inhibited by cytochalasin B, and phloridzin > phloretin. Mannitol, sorbitol, and fructose do not inhibit uptake, but o-galactose 
inhibits uptake > L-glucose > D-glucose. The apparent K m of this transport system is 311 + 47 (S.D.)/~M and the apparent V~a ~ is 40.8 + 
2.8 (S.D.) pmol.mg protein -1.min -1. This transport system may be a key in the maintenance of high tissue concentrations as it could concentrate 
myo-inositol from the plasma into the extracellular spaces of the eye and central nervous system. 
INTRODUCTION 
Myo-inosi tol  is an impor tan t  precursor  to the biosyn- 
thesis of  inositol  phosphol ip ids  and inositol phosphates ,  
compounds  which play an impor tant  role in signal 
t ransduct ion 3'19. In mammals ,  myo-inosi tol  is present  in 
p lasma at concentra t ions  ranging from 25 to 100/~M 12" 
14,17 Int racel lu lar  concentrat ions  of myo-inosi tol  are 
several-fold higher  than in the circulation, with brain and 
neurore t ina l  tissue having the highest concentrat ions 2" 
17,18,21. Al though  high intracel lular  concentrat ions could 
be main ta ined  ei ther  by active myo-inosi tol  t ranspor t  or  
by synthesis from glucose,  t ranspor t  appears  to be the 
pr imary  mechanism for two reasons.  First ,  the activity of 
the rate  l imiting enzyme in the synthesis of  myo-inosi tol ,  
inositol  1-phosphate  synthetase (EC.5.5.1.4) ,  is low in 
most  tissues 28. Second,  e levated plasma glucose concen- 
t ra t ions are associated with lowered ra ther  than e levated 
myo-inosi tol  tissue concentra t ions  8'1°'13'15'18. 
Cerebrosp ina l  fluid (CSF) and ocular  vi treous humor  
concentra t ions  of myo-inosi tol  are also higher than 
p lasma levels 17'18"23. Transport  of  this compound  from 
blood to brain in vivo and by the isolated choroid plexus 
in vitro has been  repor ted  24. However ,  active t ransport  
systems capable  of  maintaining myo-inosi tol  concentra-  
tion gradients  between plasma and CSF or  vi treous 
humor  have not  been previously described in endothel ia l  
cells that  form the b l o o d - b r a i n  and b lood - r e t i na l  barri-  
ers. In this repor t ,  we character ize  the t ranspor t  of  
myo-inosi tol  into cul tured endothel ia l  cells der ived from 
bovine ret inal  microvessels.  Ret inal  microvessels display 
similar structural  and functional  proper t ies  to brain 
microvessels,  and endothel ia l  cells in each form b l o o d -  
tissue barriers .  We show here  that  myo-inosi tol  is 
t ranspor ted  by an active t ranspor t  process dependen t  on 
the t ransmembrane sodium gradient and inhibited by 
glucose galactose, phloridzin, phloretin and cytochalasin B. 
MATERIALS AND METHODS 
Cell acquisition and culture 
Retinal endothelial cells were obtained by a modification of 
methods previously described 6. Bovine eyes were obtained from the 
slaughterhouse. Retinas were dissected, placed in ice-cold M-199 
medium supplemented with penicillin and streptomycin, and rinsed 
3 times. The retinas were strained on a 118/~m nylon mesh and 
extensively washed. The trapped tissue was washed and then 
homogenized in a glass tube with a loose fitting Teflon pestle (0.25 
mm clearance) at 400 rpm for 20 up and down strokes. The 
homogenate was centrifuged for 5 min at 1000 g. The pellet was 
resuspended in M-199 and the capillaries collected on 53/zm nylon 
mesh. The capillaries were washed into a centrifuge tube and 
centrifuged at 200 g for 2 rain. The pellet was resuspended in 0.25% 
collagenase/dispase and 0.5% bovine serum albumin in M-199 and 
gently agitated for 45-60 min. The digest was then layered over 5 
ml of Ficol-Paque and centrifuged at 1250 g for 20 min. The 
interface cells and the pellet were transferred to a T25 flask coated 
with gelatin and incubated with minimal essential medium with 
t.-valine replaced by D-valioe (MEM-o-Val) for 16--24 h. The second 
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day the medium was changed to MEM-D-Val supplemented with 16 
U/ml heparin and 50 /~g/ml of endothelial growth supplement 
(ECGS). The ceils were grown and passaged at confluency with 
splits of 1 to 4. Cells used in these experiments were in the 6th 
through 14th passage, tested positive for low density lipoprotein 
(LDL) uptake and displayed the typical endothelial cell morphology 
on phase contrast microscopy 25'26. 
Transport experiments" 
Cells were grown to confluency in 24-well (1.6 cm diameter) 
culture plates coated with fibronectin. The cells were then washed 
and preincubated for 12 rain in either an inositol-free HEPES 
buffered Dulbecco's medium, a HEPES buffered Earle's balanced 
salt solution (EBS), or sodium-free EBS with choline replacing 
sodium. The appropriate additives except for the radioactive tracers 
were included in the preincubation solutions. In the cases where 
ouabain or 2,4-dinitrophenol (2,4-DNP) and iodoacetic acid were 
used, the preincubation period was extended to 30 rain. The 
preincubation solution was aspirated off the cells and the incubation 
solution was added. At the end of the incubation, the experiment 
was stopped by the addition of 2 ml of ice-cold phosphate-buffered 
saline (PBS), pH 7.4. The cells were then quickly washed 4 more 
times over 20 s with ice-cold PBS. After the final wash, 1 N NaOH 
was added to each well. The cells were dissolved overnight at room 
temperature and then aliquots were taken for liquid scintillation 
counting and for total protein determination. When quantitation of 
lipid and inositol was undertaken, methanol was added to each well 
immediately following the final PBS wash. 
During the incubation, the medium or buffer solutions contained 
[3H]myo-inositol to measure the transport of myo-inositol and 
[14C]sucrose as a marker of the extracellular space. By measuring 
the ~4C disintegrations per minute (DPMs) in each sample, the 
contribution to the total 3H DPMs from extracellular 3H was 
determined and the intracellular label was calculated by subtracting 
the extracellular DPMs of 3H from the total 3H DPMs. 
Biochemical characterization of incorporated label 
We employed a modification of the method of Berridge to 
characterize the products of inositol incorporation 3. Immediately 
following the final wash, methanol was added to the cell layer, 
which was then scraped and both the cell layer and supernatant were 
transferred to a glass tube. The well was washed with methanol and 
the wash was combined with the sample to make a total methanol 
volume of 1 ml. To this, 0.8 ml of chloroform-HCl (200:1) was 
added, followed by 2 ml of 0.5 mM myo-inositol dissolved in water. 
The sample was then vortexed and centrifuged at 5 g for 5 min. The 
aqueous layer was separated and an aliquot of the organic layer was 
counted as an indication of myo-inositol incorporation into lipid. To 
the aqueous layer, 0.5 ml of a 50% slurry of Dowex AGI-X8 was 
added and mixed with the sample for 5 min. The sample was allowed 
to settle and the supernatant separated. The resin pellet was then 
washed twice with 5 mM myo-inositol solution. The supernatants 
and aqueous layer were pooled, frozen and lyophilized. The resin 
was counted using a liquid scintillation counter to quantitate 
myo-inositol incorporation into inositol phosphates. The lyophilate 
was resuspended in 1 ml of water and an aliquot counted to 
determine the amount of free myo-inositol. To assure the purity of 
the free myo-inositol, representative samples were then run through 
a desalting column of 1.5 × 0.6 cm consisting of Dowex l-X8 
(acetate form) and 1.5 cm × 0.6 cm amberlite CG-50 (+H form) 
with the Dowex placed above the Amberlite. The sample was eluted 
with an excess of deionized distilled water. Recovery of label from 
the column was 100%. The effluent was frozen, lyophilized, and 
reconstituted in a small volume for paper chromatography. The 
sample and standards were run in two solvent systems, n-butanol: 
ethanol:water (2:2:1) and n-butanol:pyridine:water (6:4:3) on 
Whatman 1 paper. In both systems the sample co-migrated as a 
single peak with the [3H]myo-inositol standard. 
Protein determination 
Aliquots of samples solubilized in 1 N NaOH were neutralized 
with a slight excess 1 N acetic acid. Samples were then adjusted to 
an appropriate volume and Coomassie brilliant blue G-250 dye 
solution was added. Absorbance was read at 595 nm and compared 
to a standard scale by the method of Bradford 7. Bovine gamma 
globulin was used as a protein standard. 
Water space determination 
The intracellular water space of the cultured cells was measured 
using 3-O-methyl-glucose 16. In this experiment, [3H]3-O-methyl- 
glucose was added to the cells and incubated for 45 min along with 
[14C]sucrose as a marker of extracellular water space. Since 
3-O-methyl-glucose equilibrates with the cell water during this 
period of time, the intracellular water space was calculated as the 
difference between the 3-O-methyl-glucose space and the sucrose 
space. The water space value was determined to be 7.4 + 1.2 (S.D.) 
kd/mg of protein (n = 4). 
Data analysis and statistics 
The Bonferroni modification of the t-statistic was used to make 
inferences based on the differences between the means of control 
and experimental groups 2v. For Table II, a logarithmic transforma- 
tion of the data was done prior to applying the modified t-test 
because the sample variance appeared to be proportional to the 
m e a n  values 27. 
Curve fitting for non-linear regressions (Fig. 4) was done by the 
method of least squares (SYSTAT, Systat, Evanston, IL). Our 
model equation was V = (Vmax*[S])/(K m + [S]). We also attempted 
to fit our data to a dual transport model but were not able to get 
a better fit both when no suggested solutions, and when suggested 
solutions from the literature were supplied. Linear regression of the 
sodium independent transport was also performed by the method of 
least squares (Fig. 4). 
Materials 
Cell culture medium, fetal calf serum, calf serum, penicillin, and 
streptomycin were purchased from GIBCO Laboratories, Grand 
Island, NY. ECGS was purchased from Collaborative Research, 
Lexington, MA. [3H]myo-inositol and [anC]sucrose were obtained 
from American Radiolabeled Chemicals, St. Louis, MO. [3H]3- 
O-methyl-glucose was obtained from New England Nuclear, 
Boston, MA. Bovine immunoglobulin and Coomassie brilliant blue 
were acquired from Bio-Rad, Richmond, CA. Acetylated low 
density lipoprotein labeled with l,l'-dioctadecyl-l-l-3,3,3",3"-tetra- 
methyl-indo-carbocyanine perchlorate was acquired from Biomed- 
ical Technologies, Stoughton, MA. All other chemicals were 
purchased from Sigma, St. Louis, MO. Tissue culture plates and 
flasks were obtained from Costar, Cambridge, MA. 
RESULTS 
Temperature dependence o f  inositol transport and accu- 
mulation 
Fig. 1 shows  t he  t ime  c o u r s e  o v e r  80 m i n  for  u p t a k e  of  
myo- inos i t o l  by  c u l t u r e d  e n d o t h e l i a l  cells d e r i v e d  f r o m  
re t ina l  mic rovesse l s .  T h e  d a t a  a re  e x p r e s s e d  as a ra t io  of  
the  ce l lu la r  c o n c e n t r a t i o n  to  t he  cu l t u r e  m e d i u m  c o n c e n -  
t r a t i o n  of  3H, c a l c u l a t e d  us ing  t h e  m e a s u r e d  v a l u e  o f  7 .4  
~ l / m g  p r o t e i n  for  t he  i n t r a c e l l u l a r  w a t e r  space .  O v e r  this  
t ime  c o u r s e  t h e  u p t a k e  is l i nea r  a n d  t e m p e r a t u r e  d e p e n -  
den t .  Va lues  g r e a t e r  t h a n  o n e  s h o w  t h a t  t h e r e  is 
a c c u m u l a t i o n  of  labe l  f r o m  the  m e d i u m  in to  t he  cells so 
the  i n t r a c e l l u l a r  c o n c e n t r a t i o n  is g r e a t e r  t h a n  t he  m e d i u m  
c o n c e n t r a t i o n .  Th i s  a c c u m u l a t i o n  c o u l d  b e  t he  r e su l t  of  
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Fig. 1. Time course of myo-inositol uptake and incorporation into 
cultured retinal endothelial cells. Each point represents the mean of 
5 replicates and the error bars are S.D. The data are presented as 
a concentration ratio of the intracellular concentration to the 
extracellular concentration. The extracellular ambient myo-inositol 
concentration was 6/~M and water space of cells measured 7.4/~l/mg 
protein. 
olism of myo-inositol to other compounds which would 
account for the accumulation of label, but not cause an 
increase in the intracellular free myo-insositol concentra- 
tion. 
Metabolism of inositol 
Cellular uptake of myo-inositol and incorporation of 
myo-inositol into lipid and inositol phosphates over 
21.5 h is shown in Fig. 2. The accumulation of labeled 
myo-inositol remains linear for the entire period. At 
early time points, virtually all of the accumulated label is 
in the free myo-inositol fraction. With time, an increasing 
amount of label is incorporated into lipid and then into 
inositol phosphates. To assess the purity of the myo- 
inositol fraction, samples were desalted and subjected to 
paper chromatography in 2 solvent systems. 3H from the 
TABLE I 
Effect of sodium replacement, ouabain, and energy metabolism 
inhibitors on myo-inositol transport 
Incubations were conducted in EBS with the appropriate additives, 
and in sodium-free EBS (choline buffer). Sodium chloride and 
choline chloride were present at 150 mM. Ouabain was present at 0.1 
mM, 2,4-DNP at 0.1 mM and iodoacetic acid at 5 raM. The 
extracellular myo-inositol concentration was 0.15 ~M. Values are the 
mean of 6 replicates + S.D. 
Condition fmol.mg protein 1.min-I 
Control buffer 67.7 + 1.4 
Choline buffer 14.0 + 1.0"* 
Ouabain 32.6 + 2.1"* 
2,4-DNP + iodoacetic acid 34.9 + 1.4"* 
**P < 0.005 compared to 150 mM Na ÷. 
myo-inositol fraction co-migrated as a single peak with 
the myo-inositol standard. Taken together, these experi- 
ments demonstrate that metabolism does not account for 
the accumulation of intracellular myo-inositol. There- 
fore, myo-inositol is actively transported into these cells. 
In order to minimize the effect of metabolism of 
[3H]myo-inositol during long incubations, the remainder 
of the experiments were confined to 150 min or less. 
Sodium gradient dependence of myo-inositol transport 
Active transport in mammalian cells is accomplished 
either by directly using high-energy phosphorylated 
compounds or by deriving energy from the sodium 
gradient across the cell membrane through co-transport. 
Table I shows the results from an experiment measuring 
myo-inositol uptake in the presence of ouabain, 2,4-DNP 
and iodoacetic acid, or in sodium-free EBS. The greatest 
inhibition of transport occurred in the sodium-free EBS. 
Inhibition of Na+,K÷-ATPase with ouabain, or disrup- 
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Fig. 2. Uptake and incorporation of myo-inositol into intracellular 
myo-inositol, inositol phospholipids, and inositol phosphates. Each 
value represents the mean of 4 replicates with error bars showing the 
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Fig. 3. Effect of sodium concentration on myo-inositol transport. 
Each sample represents the mean of 6 replicates with the error bars 
representing S.D. The ambient extracellular myo-inositol concen- 
tration was 2.4 ~M. 
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Fig. 4. Kinetics of myo-inositol transport into cultured retinal 
endothelial cells. The solid squares represent the sodium-dependent 
myo-inositol transport. These values were calculated by subtracting 
the measured sodium-independent transport (open triangles) from 
the total myo-inositol transport (not shown). The inset shows the 
portion of the Lineweaver-Burk transformation for data points 
closest to the Y-axis. No weighting of points was performed. 
tion of energy metabolism with 2,4-DNP and iodoacetic 
acid, also reduced myo-inositol transport, although not to 
as great an extent as did sodium replacement. Fig. 3 
shows the velocity of inositol transport as a function of 
the extracellular sodium concentration. The velocity of 
myo-inositol transport increases with increasing extracel- 
lular sodium, suggesting that the rate of transport is 
dependent upon the sodium gradient. 
Kinetic parameters of inositol transport 
The initial velocity of myo-inositol transport as a 
function of culture medium myo-inositol concentration is 
T A B L E  II 
Effects of various inhibitors on myo-inositol transport 
Values are the means  of 4 replicates + S.D. 
Compound Concentration pmol. mg 
(raM) protein l.min -1 
Control  medium - 3.50 _+ 0.81 
Hexitols 
Myo-inositol 20 0.66 + 0.09"* 
Mannitol  20 2.84 + 0.21 
Sorbitol 20 3.36 _+ 0.68 
Hexoses  
Fructose 20 2.79 + 0.06 
D-Glucose 20 2.10 _+ 0.22* 
L-Glucose 20 1.72 --+ 0.45 * * 
D-Galactose 20 1.52 + 0.41 * * 
Glucose transport  inhibitors 
Phloretin 0.2 1.90 + 0.39* 
Phloridzin 0.2 0.65 + 0.15"* 
Cytochalasin B 0.02 1.65 + 0.35** 
*P < 0.05, **P < 0.005, compared to the control medium with a 
glucose concentrat ion of 5.0 mM  and an ambient  myo-inositol 
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Fig. 5. Effect of glucose on the t ransport  of  myo-inositol.  The  open 
squares show the amount  of  myo-inositol t ransported at various 
glucose concentrat ions ranging between 0.5 and 40 mM. The 
myo-inositol concentrat ion was 40/~M. 
shown in Fig. 4. The portion of the transport which is 
sodium independent (as measured in a sodium-free 
choline buffer) is much less than the portion which is 
sodium dependent. The apparent K m for the sodium- 
dependent uptake was 311 __ 47 (S.D.) ~M and the Vm~ , 
was 40.8 + 2.8 (S.D.) pmol.mg protein-a.min -1. 
Specificity of the inositol transport system 
Inositol uptake was finally characterized by measuring 
transport in the presence of various hexoses, hexitols, 
and inhibitors of the glucose transport system. The 
results are shown in Table II. Cold myo-inositol is a very 
potent inhibitor of radioactive myo-inositol transport, but 
the other two tested hexitols, mannitol and sorbitol, did 
not significantly inhibit myo-inositol transport. Fructose 
did not inhibit transport, but D-galactose, D-glucose and 
L-glucose all significantly inhibited myo-inositol trans- 
port. Finally, phloretin, phloridzin, and cytochalasin B 
inhibited myo-inositol transport, but the order of potency 
is different than that for the inhibition of glucose 
transport, with phloridzin being a more potent inhibitor 
of myo-inositol transport than phloretin 4. 
Fig. 5 shows the increasing inhibition of myo-inositol 
transport with increasing concentrations of glucose. It is 
important to note that even at physiologic glucose and 
myo-inositol concentrations, the transport of myo-ino- 
sitol is inhibited to a measurable extent. 
DISCUSSION 
Endothelial cells derived from retinal microvessels 
were chosen for this study because they form the 
blood-tissue barrier at the retinal capillary and prevent 
many molecules found in the plasma from entering the 
retina. The function and structure of the blood-retinal 
barrier is very similar to the that of the blood-brain 
barrier  s . In addition to excluding certain molecules from 
the eye and brain, these barriers also tend to buffer 
tissues from swings in plasma concentrations of other 
molecules, such as amino acids and glucose. Specialized 
transport systems exist at blood-tissue barriers to permit 
certain molecules to pass from the circulation into tissues. 
The major transport system for myo-inositol uptake into 
cultured bovine retinal microvessel endothelial cells is a 
saturable, carrier-mediated, active process deriving its 
energy from the sodium gradient. Myo-inositol is con- 
centrated in these cells to levels well above the concen- 
trations present in the cell culture medium. The apparent 
K m of 311 + 47 (S.D.) pM, found in vitro suggests that 
the rate of transport of myo-inositol across the barrier in 
vivo is dependent upon the plasma myo-inositol concen- 
tration. Uptake is inhibited by replacement of sodium 
with choline or by addition of ouabain; both observations 
indicate sodium-dependent transport. Finally, uptake is 
inhibited by cytochalasin B, phloretin, phloridzin, D- 
glucose, L-glucose, galactose, but not by fructose, man- 
nitol or sorbitol added to the cell culture medium. The 
order of potency of the transport inhibitors, the sodium- 
dependence, and the inhibition by L-glucose permit us to 
conclude that myo-inositol is not transported by means of 
the major glucose facilitated-diffusion transport system 4. 
Even under physiologic concentrations of glucose and 
myo-inositol, there is measurable inhibition of transport 
by glucose. Since our kinetic analysis was performed in 
the presence of 5 mM o-glucose, the calculated Mi- 
chaelis-Menten constant represents an apparent Kin. 
The transport of myo-inositol into neural cells in 
culture has also been studied. Cultured rat Schwann cells 
have a saturable sodium-dependent transport system 2°. 
As in endothelial cells, transport is inhibited by glucose, 
galactose, phloridzin and phloretin. In this system, the 
Km was 30/~M. In mouse neuroblastoma cells grown in 
culture, Yorek et al. 29 found two saturable sodium- 
dependent transport systems, a high-affinity transport 
system with a K~ value of 12.4 ~M and a Vma x of 14.1 
pmol.mg protein-l 'min -~ and a low-affinity system with 
a K m of 433 ~M and a Vm~x of 215 pmol.mg pro- 
tein-X.min -1. Myo-inositol transport into neuroblastoma 
cells was inhibited by glucose and by sorbitol 3°. In doing 
these inhibitor studies, the cells were preincubated with 
inhibitor for two weeks in the presence of sorbitol and in 
30 mM glucose. The inhibition by 30 mM glucose had 
both competitive and non-competitive components, with 
the non-competitive inhibition being greater. The long 
preincubation time may account for the differeces in the 
nature of the glucose and sorbitol inhibition these authors 
observed compared to other investigators. 
In the central nervous system, the tissue concentra- 
tions of myo-inositol are tightly controlled 1'11. Normal 
cerebral and cerebellar myo-inositol concentrations are 
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maintained even in the presence of dietary restriction 1. 
Spector described a 3 tier system of myo-inositol ho- 
meostasis in brain 22. The first level is regulated by renal 
excretion and intestinal absorption. The second level is 
transported into the central nervous system by the 
choroid plexus. The third level is by carrier-mediated 
transport from interstitial fluid into brain cells. 
The active transport of myo-inositol by retinal micro- 
vessel endothelial cells at the blood-retinal barrier may 
be fundamental to its high concentration in the retina. 
The retinal capillary is similar to the structure of the 
cerebral capillary in terms of tight junctions and special- 
ized transport systems which protect neural tissue from 
fluctuations in the concentrations of plasma compo- 
nents 5. Both the brain and the retina have tissue 
myo-inositol concentrations that are much higher than 
plasma. Concentrations of myo-inositol in the vitreous 
humor and the CSF probably approximate the concen- 
trations in retinal and brain interstitial fluid because there 
are no barriers to diffusion between these fluid spaces for 
small polar molecules 5'9. These fluids have a myo-inositol 
concentration greater than the plasma but less than the 
concentrations in the adjacent tissues 17'18. Since myo- 
inositol is concentrated from the plasma into the extra- 
cellular fluid of the eye and brain, we presume that the 
transport system we describe into cultured retinal endo- 
thelial cells in vivo is located on the luminal border of the 
capillaries. Also implicit in this model is a mechanism for 
release of myo-inositol at the anti-luminal border which 
allows myo-inositol to flow out of the cell into the 
interstitial fluid. For the brain, myo-inositol transport 
may occur both at the capillary endothelium into inter- 
stitial fluid, and at the choroid plexus into spinal fluid. 
For the eye, myo-inositol transport would occur at the 
capillary endothelial cell into the retinal interstitial fluid. 
The source of myo-inositol in the vitreous humor is not 
known, but transport by the ciliary body into the aqueous 
humor with subsequent diffusion into the vitreous, and 
transport by the pigmented retinal epithelium may 
supplement diffusion into the vitreous from retinal 
interstitial fluid. Retinal and cerebral parenchymal cells 
further concentrate interstitial myo-inositol. In effect, 
there is a serial concentration of myo-inositol, first across 
the blood-tissue barrier, and second into the parenchy- 
mal cells of the retina and the brain. Coupling the 
myo-inositol pumps in series may explain how these two 
tissues maintain high concentrations of myo-inositol. 
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